The Genetic Basis of Escherichia coli Pathoadaptation to Macrophages

被引:60
作者
Miskinyte, Migla [1 ]
Sousa, Ana [1 ]
Ramiro, Ricardo S. [1 ]
Moura de Sousa, Jorge A. [1 ]
Kotlinowski, Jerzy [1 ]
Caramalho, Iris [1 ,2 ]
Magalhaes, Sara [3 ]
Soares, Miguel P. [1 ]
Gordo, Isabel [1 ]
机构
[1] Inst Gulbenkian Ciencias, Oeiras, Portugal
[2] Univ Lisbon, Fac Med, Inst Mol Med, Unidade Imunol Clin, P-1699 Lisbon, Portugal
[3] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal
基金
欧洲研究理事会;
关键词
SMALL-COLONY-VARIANT; MUCOID PSEUDOMONAS-AERUGINOSA; MICROBIAL PATHOGENESIS; ANTIBIOTIC-RESISTANCE; PHOSPHORELAY SYSTEM; CAPSULE SYNTHESIS; RCS PHOSPHORELAY; CYSTIC-FIBROSIS; IMMUNE EVASION; MUTATIONS;
D O I
10.1371/journal.ppat.1003802
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Antagonistic interactions are likely important driving forces of the evolutionary process underlying bacterial genome complexity and diversity. We hypothesized that the ability of evolved bacteria to escape specific components of host innate immunity, such as phagocytosis and killing by macrophages (MW), is a critical trait relevant in the acquisition of bacterial virulence. Here, we used a combination of experimental evolution, phenotypic characterization, genome sequencing and mathematical modeling to address how fast, and through how many adaptive steps, a commensal Escherichia coli (E. coli) acquire this virulence trait. We show that when maintained in vitro under the selective pressure of host MW commensal E. coli can evolve, in less than 500 generations, virulent clones that escape phagocytosis and MW killing in vitro, while increasing their pathogenicity in vivo, as assessed in mice. This pathoadaptive process is driven by a mechanism involving the insertion of a single transposable element into the promoter region of the E. coli yrfF gene. Moreover, transposition of the IS186 element into the promoter of Lon gene, encoding an ATP-dependent serine protease, is likely to accelerate this pathoadaptive process. Competition between clones carrying distinct beneficial mutations dominates the dynamics of the pathoadaptive process, as suggested from a mathematical model, which reproduces the observed experimental dynamics of E. coli evolution towards virulence. In conclusion, we reveal a molecular mechanism explaining how a specific component of host innate immunity can modulate microbial evolution towards pathogenicity.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 71 条
[21]   REGULATION OF CAPSULAR POLYSACCHARIDE SYNTHESIS IN ESCHERICHIA-COLI K12 [J].
GOTTESMAN, S ;
STOUT, V .
MOLECULAR MICROBIOLOGY, 1991, 5 (07) :1599-1606
[22]   Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia [J].
Govan, JRW ;
Deretic, V .
MICROBIOLOGICAL REVIEWS, 1996, 60 (03) :539-+
[23]   An equivalence principle for the incorporation of favorable mutations in asexual populations [J].
Hegreness, M ;
Shoresh, N ;
Hartl, D ;
Kishony, R .
SCIENCE, 2006, 311 (5767) :1615-1617
[24]   Intracellular Lifestyles and Immune Evasion Strategies of Uropathogenic Escherichia coli [J].
Hunstad, David A. ;
Justice, Sheryl S. .
ANNUAL REVIEW OF MICROBIOLOGY, VOL 64, 2010, 2010, 64 :203-221
[25]   Modulation of cellular function by polyamines [J].
Iarashi, Kazuei ;
Kashiwagi, Keiko .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2010, 42 (01) :39-51
[26]   Fatal Escherichia coli skin and soft tissue infections in liver transplant recipients: report of three cases [J].
Janny, S. ;
Bert, F. ;
Dondero, F. ;
Chanoine, M. -H. Nicolas ;
Belghiti, J. ;
Mantz, J. ;
Paugam-Burtz, C. .
TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (02) :E49-E53
[27]   Killing by ampicillin and ofloxacin induces overlapping changes in Escherichia coli transcription profile [J].
Kaldalu, M ;
Mei, R ;
Lewis, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (03) :890-896
[28]  
Kerr DR, 1996, ENVIRON TOXICOL CHEM, V15, P395, DOI [10.1897/1551-5028(1996)015<0395:MDRUGL>2.3.CO
[29]  
2, 10.1002/etc.5620150325]
[30]   Genetic Determinants of Resistance to Fusidic Acid among Clinical Bacteremia Isolates of Staphylococcus aureus [J].
Lannergard, Jonas ;
Norstrom, Tobias ;
Hughes, Diarmaid .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) :2059-2065